Early genetic testing can identify rare, treatable epilepsies in infants, often missed by standard diagnostics. A recent case in India revealed a rare ALDH7A1 gene mutation, enabling targeted treatment. Dr. Thenral S Geetha, Principal Scientist at MedGenome, highlights the urgent need to integrate genetic testing into routine pediatric care to bridge India's epilepsy treatment gap.